Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
92.3M
-
Number of holders
-
258
-
Total 13F shares, excl. options
-
90.6M
-
Shares change
-
-2.36M
-
Total reported value, excl. options
-
$4.55B
-
Value change
-
-$106M
-
Put/Call ratio
-
1.3
-
Number of buys
-
123
-
Number of sells
-
-120
-
Price
-
$50.26
Significant Holders of Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) as of Q4 2020
289 filings reported holding ACHC - Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share as of Q4 2020.
Acadia Healthcare Company, Inc. - Common Stock, par value $0.01 per share (ACHC) has 258 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 90.6M shares
of 92.3M outstanding shares and own 98.16% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (10.3M shares), WELLINGTON MANAGEMENT GROUP LLP (9.38M shares), VANGUARD GROUP INC (7.92M shares), BlackRock Inc. (7.57M shares), DIMENSIONAL FUND ADVISORS LP (6.02M shares), JPMORGAN CHASE & CO (3.61M shares), P2 Capital Partners, LLC (3.27M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (2.71M shares), Bank of New York Mellon Corp (2.34M shares), and STATE STREET CORP (2.17M shares).
This table shows the top 258 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.